Cited by 2,144Cancer Cells and MetastasisEffects of Radiation ExposureCancer, Hypoxia, and Metabolism

The DOI matches its Crossref record; 200 of the 200 references it cites were found in a registry or an index.

The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence

Open access

Barker, Holly E., Paget, James T. E., Khan, Aadil A., Harrington, Kevin J.·2015·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Radiotherapy plays a central part in curing cancer. For decades, most research on improving treatment outcomes has focused on modulating radiation-induced biological effects on cancer cells. Recently, we have better understood that components within the tumour microenvironment have pivotal roles in determining treatment outcomes. In this Review, we describe vascular, stromal and immunological changes that are induced in the tumour microenvironment by irradiation and discuss how these changes may promote radioresistance and tumour recurrence. We also highlight how this knowledge is guiding the development of new treatment paradigms in which biologically targeted agents will be combined with radiotherapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrc3958

Cites

200 of 200 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

RETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
Lee, K., Zhang, H., Qian, D. Z., Rey, S., Liu, J. O., & Semenza, G. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909353106 · Cited by 451
Retracted
MMP-2 siRNA Inhibits Radiation-Enhanced Invasiveness in Glioma Cells
Badiga, A. V., Chetty, C., Kesanakurti, D., Are, D., Gujrati, M., Klopfenstein, J. D., Dinh, D. H., & Rao, J. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020614 · Cited by 110
Retracted
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Pattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177

Show all 200 references

Sorted by citations

Items 801–900 of 1,005

A Two‐Step Flexible Ultrasound Strategy to Enhance Tumor Radiotherapy via Metal–Phenolic Network Nanoplatform
Tian, Y., Sang, W., Tian, H., Xie, L., Wang, G., Zhang, Z., Li, W., & Dai, Y. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202205690 · Cited by 27
Delivery of DNA octahedra enhanced by focused ultrasound with microbubbles for glioma therapy
Shen, Y., Hu, M., Li, W., Chen, Y., Xu, Y., Sun, L., Liu, D., Chen, S., Gu, Y., Ma, Y., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.019 · Cited by 29
Fe/MOF based platform for NIR laser induced efficient PDT/PTT of cancer
Liang, Z., Li, X., Chen, X., Zhou, J., Li, Y., Peng, J., Lin, Z., Liu, G., Zeng, X., Li, C., et al. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1156079 · Cited by 28
“It is well known that hypoxia is a major feature of solid tumors (Barker et al., 2015; Courtnay et al., 2015; Meng et al., 2018), that is because the malignant proliferation of tumor cells is always faster than the formation of vascular network.”
Background
Combination of bacterial-targeted delivery of gold-based AIEgen radiosensitizer for fluorescence-image-guided enhanced radio-immunotherapy against advanced cancer
Duo, Y., Chen, Z., Li, Z., Li, X., Yao, Y., Xu, T., Gao, G., & Luo, G. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.05.010 · Cited by 28
“Moreover, some malignancies possess low sensitivity or resistance compared to normal tissues that result to low RT efficiency [4,5].”
Background
Emerging from their burrow: Hedgehog pathway inhibitors for cancer
Gan, G. N., & Jimeno, A. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1216973 · Cited by 28
“ways and may have a profound effect on tumor myofibroblasts [140].”
Background
Candidate immune biomarkers for radioimmunotherapy
Lévy, A., Nigro, G., Sansonetti, P. J., & Deutsch, É. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.02.006 · Cited by 28
Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib
Verginelli, F., Perconti, S., Vespa, S., Schiavi, F., Prasad, S. C., Lanuti, P., Cama, A., Tramontana, L., Esposito, D. L., Guarnieri, S., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-017-1799-2 · Cited by 28
“All this should confer resistance to radio/chemotherapy and standard antiangiogenic therapy [2, 5, 54, 66], and could account for PGL recurrence after treatments that induce ischemic necrosis, such as embolization [61].”
Background
Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts
Žakelj, M. N., Prevc, A., Kranjc, S., Čemažar, M., Todorović, V., Savarin, M., Ščančar, J., Kosjek, T., Grošelj, B., Strojan, P., et al. (2019) · Oncology Reports · doi:10.3892/or.2019.6960 · Cited by 29
“…the differences in the response rate of pre-irradiated tumors to non-surgical treatment modalities could also be the result of changes in the tumor microenvironment after irradiation that may promote tumor invasion and spread through the effects on tumor vasculature, stroma and immune system (22).”
Radioresponsive Delivery of Toll-like Receptor 7/8 Agonist for Tumor Radioimmunotherapy Enabled by Core-Cross-Linked Diselenide Nanoparticles
Wu, Y., Qin, J., Gu, Y., Zhao, G., Xu, P., Lin, S., Cheng, X., Zhang, L. W., Wang, Y., & Wang, Y. (2024) · ACS Nano · doi:10.1021/acsnano.3c05882 · Cited by 27
A Novel Activatable Nanoradiosensitizer for Second Near‐Infrared Fluorescence Imaging‐Guided Safe‐Dose Synergetic Chemo‐Radiotherapy of Rheumatoid Arthritis
Jin, Y., Li, D., Zheng, X., Gao, M., Wang, W., Zhang, X., Kang, W., Zhang, C., Wu, S., Dai, R., et al. (2024) · Advanced Science · doi:10.1002/advs.202308905 · Cited by 27
The research progress on radiation resistance of cervical cancer
Liang, M., Sheng, L., Ke, Y., & Wu, Z. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1380448 · Cited by 28
A Salidroside‐Based Radiosensitizer Regulates the Nrf2/ROS Pathway for X‐Ray Activated Synergistic Cancer Precise Therapy
Li, Q., Chen, Q., Xiao, S., Wang, S., Ge, X., Wang, Q., Zheng, L., Wei, Q., Du, W., Shen, W., et al. (2025) · Advanced Materials · doi:10.1002/adma.202413226 · Cited by 29
Low doses of ionizing radiation activate endothelial cells and induce angiogenesis in peritumoral tissues
Marques, F. G., Poli, E., Malaquias, J., Carvalho, T., Portêlo, A., Ramires, A., Aldeia, F., Ribeiro, R. M., Vitorino, E., Diegues, I., et al. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.06.038 · Cited by 27
Exploring Radiation Response in Two Head and Neck Squamous Carcinoma Cell Lines Through Metabolic Profiling
Jonsson, E. L., Erngren, I., Engskog, M. K. R., Haglöf, J., Arvidsson, T., Hedeland, M., Petterson, C., Laurell, G. F. E., & Nestor, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00825 · Cited by 29
Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer
Li, L., Huang, S., Yao, Y., Chen, J., Li, J., Xiang, X., Deng, J., & Xiong, J. (2020) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-02070-9 · Cited by 27
“The interaction between tumor cells and TME plays a crucial role in tumor growth, progression, chemotherapy, and radiotherapy resistance [39-41].”
Background
Engineering nanomedicines to inhibit hypoxia-inducible Factor-1 for cancer therapy
Zhang, X., He, C., & Xiang, G. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.01.012 · Cited by 28
ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group
Fleischmann, M., Diefenhardt, M., Nicolas, A. M., Rödel, F., Ghadimi, M. B., Hofheinz, R., Greten, F. R., Rödel, C. M., & Fokas, E. (2022) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2022.04.003 · Cited by 28
“Recently, components of TME have become increasingly recognized as important modulators of disease progression and treatment response [21].”
Background
The Autologous Hematopoietic Stem Cells Transplantation Combination-Based Chimeric Antigen Receptor T-Cell Therapy Improves Outcomes of Relapsed/Refractory Central Nervous System B-Cell Lymphoma
Xue, F., Zheng, P., Liu, R., Feng, S., Guo, Y., Shi, H., Liu, H., Deng, B., Xu, T., Ke, X., et al. (2022) · Journal of Oncology · doi:10.1155/2022/2900310 · Cited by 27
The role of microRNA-induced apoptosis in diverse radioresistant cancers
Darvish, L., Toossi, M. T. B., Azimian, H., Shakeri, M., Dolat, E., Firouzjaei, A. A., Rezaie, S., Amraee, A., & Aghaee‐Bakhtiari, S. H. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110580 · Cited by 27
Different Expression and Clinical Implications of Cancer-Associated Fibroblast (CAF) Markers in Brain Metastases
Akanda, M. R., Ahn, E., Kim, Y. J., Salam, S. M. A., Noh, M., Kim, S. S., Jung, T., Kim, I., Kim, C., Lee, K., et al. (2023) · Journal of Cancer · doi:10.7150/jca.80115 · Cited by 29
“Previous studies revealed that chemotherapy for the primary tumor induced chemo-resistance and facilitated metastatic colonization, recruitment of immune and stromal cells and tumor recurrence through angiogenesis as well [46, 47].”
Background
Enhancement of radiotherapy efficacy by pleiotropic liposomes encapsulated paclitaxel and perfluorotributylamine
Jiang, X., Zhang, B., Zhou, Z., Meng, L., Sun, Z., Xu, Y., Xu, Q., Yuan, A., Yu, L., Qian, H., et al. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1378939 · Cited by 27
“Radiotherapy (RT) is one of the most frequently used treatments for tumors in clinic, and it is reported that more than 50% of cancer patients require RT (Barker et al., 2015).”
Background
Synergistic Effects of NOTCH/γ-Secretase Inhibition and Standard of Care Treatment Modalities in Non-small Cell Lung Cancer Cells
Iglesias, V. S., Theys, J., Groot, A. J., Barbeau, L. M. O., Lemmens, A., Yaromina, A., Losen, M. H., Houben, R. M. A., Dubois, L. J., & Vooijs, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00460 · Cited by 27
Differential regulation of microRNA-15a by radiation affects angiogenesis and tumor growth via modulation of acid sphingomyelinase
Rana, S. R., Espinosa‐Díez, C., Ruhl, R. A., Chatterjee, N., Hudson, C., Fraile‐Bethencourt, E., Agarwal, A., Khou, S., Thomas, C. R., & Anand, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-62621-8 · Cited by 27
“Dose escalation does not only augments DNA damage but also involves a vast number of tumor microenvironment (TME) regulators (11).”
Background
MiR-499a-5p Inhibits Pr5/4/20 publish l Cancer Cells via Targeting eIF4E
Gu, X., Dong, M., Liu, Z., Yang, J., & Shi, Y. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s241631 · Cited by 27
“However, in clinical practices, a few patients often develop resistance to radiotherapy, resulting in unsatisfactory outcomes and even tumor recurrence and metastasis.(3) In addition to the clinicopathological features, the molecular biological characteristics of cancer cells might be the potential influencing factors…”
Background
Radioiodine based biomedical carriers for cancer theranostics
Guo, J., Xiong, H., Liu, H., Zhang, T., & Sun, X. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215430 · Cited by 26
The cellular composition of the tumor microenvironment is an important marker for predicting therapeutic efficacy in breast cancer
Dou, T., Li, J., Zhang, Y., Pei, W., Zhang, B., Wang, B., Wang, Y., & Jia, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1368687 · Cited by 29
“HMGB1 can activate Toll-like receptor 4 on DCs, enhance the cross-presentation of tumor antigens, and subsequently activate the response of CTLs (14, 168).”
Background
Multifunctional Glycopeptide-Based Hydrogel via Dual-Modulation for the Prevention and Repair of Radiation-Induced Skin Injury
Guo, J., Zhang, X., Mao, R., Li, H., Hao, Y., Zhang, J., Wang, W. J., Zhang, Y., & Liu, J. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c00698 · Cited by 26
Nanozymes as Glucose Scavengers and Oxygenerators for Enhancing Tumor Radiotherapy
Zhang, Y., Li, X., Ren, X., Wang, D., Zhao, Y., Wang, Y., Jin, S., Lin, Q., Zou, K., & Wang, T. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c18066 · Cited by 27
Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours
Golubnitschaja, O., Yeghiazaryan, K., Stricker, H. M., Trog, D., Schild, H. H., & Berliner, L. (2016) · BMC Cancer · doi:10.1186/s12885-016-2382-2 · Cited by 26
“They participate in the remodelling of peritumoural stroma, which is a prerequisite of neoplastic cell invasion, expansion, and metastasis [23].”
Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors
Bolli, E., D’Huyvetter, M., Murgaski, A., Berus, D., Stangé, G. M., Clappaert, E. J., Arnouk, S. M., Antunes, A. R. P., Krasniqi, A., Lahoutte, T., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.024 · Cited by 26
“[12] Here, we propose RIT targeted to a stromal cell (stromal-targeting radioimmunotherapy or STRIT) as a therapeutic option, whereby hypoxic MMR TAMs were targeted with a (177)Lu-labeled MMR-specific Nb.”
Background
α-Lipoic acid prevents the ionizing radiation-induced epithelial-mesenchymal transition and enhances the radiosensitivity in breast cancer cells
Tripathy, J., Chowdhury, A. R., Prusty, M., Muduli, K., Priyadarshini, N., Reddy, K. S., Banerjee, B., & Elangovan, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172938 · Cited by 26
New Insights into Therapy-Induced Progression of Cancer
Shnaider, P. V., Ivanova, O. M., Malyants, I. K., Anufrieva, K. S., Semenov, I. A., Pavlyukov, M. S., Lagarkova, M. A., Govorun, V. M., & Shender, V. О. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217872 · Cited by 28
PD-1 restrains IL-17A production from γδ T cells to modulate acute radiation-induced lung injury
Sheng, Y., Chen, K., Jiang, W., Wu, Z., Zhang, W., Jing, H., Wang, L., Qu, C., & Ren, H. (2021) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-838 · Cited by 26
“This conventional therapy is generally unable to subvert the immune tolerance of the tumor (33).”
Background
Abscopal Effects in Metastatic Cancer: Is a Predictive Approach Possible to Improve Individual Outcomes?
Link, B., Crigna, A. T., Hölzel, M., Giordano, F. A., & Golubnitschaja, O. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10215124 · Cited by 27
“Decreasing tumor cells release elevated amounts of antigens, which are recognized and processed by APCs [108,109].”
BackgroundInfluential
Predictive molecular markers for the treatment with immune checkpoint inhibitors in colorectal cancer
Du, F., & Liu, Y. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24141 · Cited by 26
Radiotherapy-induced enrichment of EGF-modified doxorubicin nanoparticles enhances the therapeutic outcome of lung cancer
Wang, J., Zhang, Y., Zhang, G., Li, X., Pang, H., Xiong, K., Lü, Y., Li, J., Dai, J., Lin, S., et al. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2036871 · Cited by 26
“Radiotherapy can enhance the permeability of blood vessels (Barker et al., 2015; Stapleton et al., 2017), and a single dose of 5 Gy radiotherapy can locally burst the tumor vasculature and promote infiltration of macrophages, significantly increasing drug accumulation in the tumor.”
Background
LINC00665 knockdown confers sensitivity in irradiated non-small cell lung cancer cells through the miR-582-5p/UCHL3/AhR axis
Xu, L., Yuan, Y., Yu, H., Wang, S., & Wang, P. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03516-2 · Cited by 26
Emerging roles of purinergic signaling in anti-cancer therapy resistance
Zanoni, M., Pegoraro, A., Adinolfi, E., & Marchi, E. D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1006384 · Cited by 26
“The resulting oxidative stress can further affect DNA, lipids and proteins structures triggering the activation of stress-response signaling leading to cell death and promoting the release of inflammatory cytokines and the generation of DAMPS (Schaue and McBride, 2010; Barker et al., 2015).”
BackgroundInfluential
Novel Implications of Nanoparticle-Enhanced Radiotherapy and Brachytherapy: Z-Effect and Tumor Hypoxia
Zhou, R., Zhao, D., Beeraka, N. M., Wang, X., Lu, P., Song, R., Chen, K., & Liu, J. (2022) · Metabolites · doi:10.3390/metabo12100943 · Cited by 27
Utilizing circulating tumour DNA in radiation oncology
Rostami, A., & Bratman, S. V. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.07.004 · Cited by 26
Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
Marciscano, A. E. E., Walker, J. M., McGee, H. M., Kim, M. M., Kunos, C. A., Monjazeb, A. M., Shiao, S. L., Tran, P. T., & Ahmed, M. M. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0317-y · Cited by 27
“radiotherapy during their disease course [1].”
Radiosensitization by Marine Sponge Agelas sp. Extracts in Hepatocellular Carcinoma Cells with Autophagy Induction
Choi, C., Son, A.-R., Lee, H., Lee, Y., & Park, H. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-24745-w · Cited by 26
The Response of Prostate Cancer to Androgen Deprivation and Irradiation Due to Immune Modulation
Wu, C., Chen, W., & Chen, M. (2018) · Cancers · doi:10.3390/cancers11010020 · Cited by 26
“A tumor’s “immunological status” is of great importance when considering how to best enhance the response to treatment [31].”
Background
Impact of radiation therapy on healthy tissues
Chargari, C., Rassy, E., Hélissey, C., Achkar, S., François, S., & Deutsch, É. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.11.006 · Cited by 26
The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy
Frankish, J., Mukherjee, D., Romano, E., Frey, K., Schröder, M., Heinonen, K., Merz, C., Müller, M. R., Gieffers, C., Hill, O., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1160116 · Cited by 25
Magnetocaloric‐Responsive Hydrogel Nanoarchitectonics for Pyroptosis‐Relay‐Immunotherapy to Suppress Post‐Operation Tumor Recurrence and Metastasis
Wang, S., Jing, H., Yang, R., Heger, Z., Křížková, S., Zhou, Y., Liang, X., Adam, V., & Li, N. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202314194 · Cited by 25
The Role of αvβ3 Integrin in Cancer Therapy Resistance
Pachane, B. C., & Selistre-de-Araújo, H. S. (2024) · Biomedicines · doi:10.3390/biomedicines12061163 · Cited by 25
“It is also known that recurrent tumors may not present characteristics similar to the original mass; therefore, their treatment needs to be adjusted to target the new neoplastic microenvironment [6].”
Background
Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens
Chi, W.-Y., Hu, Y., Huang, H., Kuo, H., Lin, S., Kuo, C.-T. J., Tao, J., Fan, D., Huang, Y.-M., Wu, A. A., et al. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01082-x · Cited by 27
Targeting GOLPH3L improves glioblastoma radiotherapy by regulating STING-NLRP3–mediated tumor immune microenvironment reprogramming
Sun, S., Qian, S., Wang, R., Zhao, M., Li, R., Gu, W., Zhao, M., Qian, C., Liu, L., Tang, X., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.ado0020 · Cited by 27
The resveratrol analogue, HS‑1793, enhances the effects of radiation therapy through the induction of anti‑tumor immunity in mammary tumor growth
Kim, J., Jeong, S. K., Oh, S. J., Lee, C. G., Kang, Y. R., Jo, W. S., & Jeong, M. H. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5017 · Cited by 25
“Radiotherapy has often been associated with the recurrence or metastasis of cancer as radiation induces the resistance of tumor cells and in addition, damages healthy cells (28,37).”
Background
Re-Irradiation of Recurrent Non-Small Cell Lung Cancer
Hunter, B., Crockett, C., Finn, C. F., Hiley, C. T., & Salem, A. (2021) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2020.11.009 · Cited by 25
The role of exosomes in tumour immunity under radiotherapy: eliciting abscopal effects?
Yin, T., Xin, H., Yu, J., & Teng, F. (2021) · Biomarker Research · doi:10.1186/s40364-021-00277-w · Cited by 25
Assessment of the expression and response of PD-1, LAG-3, and TIM-3 after neoadjuvant radiotherapy in rectal cancer
Peng, Q., Li, J., Xin, P., Du, K., Lin, X.-Y., Wu, J., Zhang, M.-T., & Kong, X. (2021) · Neoplasma · doi:10.4149/neo_2021_201210n1341 · Cited by 25
Proof of concept for dual anticancer effects by a novel nanomaterial-mediated cancer cell killing and nano-radiosensitization
Duo, Y., Liu, Q., Zhu, D., Zhang, B., Luo, G., Wang, F., Jinghua, C., & Cao, Y. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.132328 · Cited by 25
Microvesicle-inspired oxygen-delivering nanosystem potentiates radiotherapy-mediated modulation of tumor stroma and antitumor immunity
Gong, X., Li, J., Xu, X., Wu, Y., Lei, Y., Liu, H., Qian, X., Li, Y., & Zhang, Z. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121855 · Cited by 25
Biomimetic Active Materials Guided Immunogenic Cell Death for Enhanced Cancer Immunotherapy
Huang, G., Liu, L., Pan, H., & Cai, L. (2022) · Small Methods · doi:10.1002/smtd.202201412 · Cited by 25
Neurons as stromal drivers of nervous system cancer formation and progression
Anastasaki, C., Gao, Y., & Gutmann, D. H. (2023) · Developmental Cell · doi:10.1016/j.devcel.2022.12.011 · Cited by 26
X-ray-responsive prodrugs and polymeric nanocarriers for multimodal cancer therapy
Cao, Y., Si, J., Zheng, M., Zhou, Q., & Ge, Z. (2023) · Chemical Communications · doi:10.1039/d3cc01398g · Cited by 25
Radiation induces acute and subacute vascular regression in a three-dimensional microvasculature model
Choi, D., Oh, D., Na, K., Kim, H., Choi, D., Jung, Y. H., Ahn, J.-C., Kim, J., Kim, C., & Chung, S. H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1252014 · Cited by 27
Injectable hydrogel-based drug delivery systems for enhancing the efficacy of radiation therapy: A review of recent advances
Xu, N., Wang, J., Liu, L., & Gong, C. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.109225 · Cited by 25
Tumor-associated macrophages in non-small-cell lung cancer: From treatment resistance mechanisms to therapeutic targets
Huang, Z., Xiao, Z., Yu, L., Liu, J., Yang, Y., & Ouyang, W. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104284 · Cited by 29
Low Mast Cell Density Predicts Poor Prognosis in Oral Squamous Cell Carcinoma and Reduces Survival in Head and Neck Squamous Cell Carcinoma
Attramadal, C. G., KUMAR, S., Gao, J., Boysen, M., Halstensen, T. S., & Bryne, M. (2016) · Anticancer Research · doi:10.21873/anticanres.11131 · Cited by 25
The immune mediated role of extracellular HMGB1 in a heterotopic model of bladder cancer radioresistance
Ayoub, M., Shinde-Jadhav, S., Mansure, J. J., Alvarez, F., Connell, T., Seuntjens, J. P., Piccirillo, C. A., & Kassouf, W. (2019) · Scientific Reports · doi:10.1038/s41598-019-42864-w · Cited by 25
Antioxidants suppress radiation-induced apoptosis via inhibiting MAPK pathway in nasopharyngeal carcinoma cells
Meng, D., Guo, L., Peng, L., Zheng, L., Xie, P., Mei, Y., Li, C., Peng, X., Lang, Y., Liu, Z., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.04.093 · Cited by 25
Cancer‑related fatigue during combined treatment of androgen deprivation therapy and radiotherapy is associated with mitochondrial dysfunction
Feng, L., Wolff, B. S., Liwang, J. K., Regan, J. M., Alshawi, S. A., Raheem, S. A., & Saligan, L. N. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4435 · Cited by 25
“RT uses ionizing radiation to induce double-stranded dNA breaks in cancer cells and is well-established as an effective treatment for localized prostate cancer (4).”
Background
Propofol Inhibits the Progression of Cervical Cancer by Regulating HOTAIR/miR-129-5p/RPL14 Axis
Sun, N. C., Zhang, W., Liu, J., Yang, X., & Chu, Q. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s279942 · Cited by 25
Mixed-valence Pt(0)/Pt2+ nanoassemblies as high-Z radiosensitizers and metallo-immune regulators for potent radiotherapy of breast cancer
Zhang, F., Feng, L., Jia, C., Wu, Y., Liu, J., Shuai, X., & Cao, Z. (2023) · Nano Today · doi:10.1016/j.nantod.2022.101708 · Cited by 26
Clinical Radiobiology for Radiation Oncology
Sminia, P., Guipaud, O., Viktorsson, K., Ahire, V. R., Baatout, S., Boterberg, T., Čížková, J., Dostál, M., Fernández-Palomo, C., Filipová, A., et al. (2023) · Springer eBooks · doi:10.1007/978-3-031-18810-7_5 · Cited by 31
How Imaging Advances Are Defining the Future of Precision Radiation Therapy
García‐Figueiras, R., Baleato‐González, S., Luna, A., Padhani, A. R., Vilanova, J. C., Carballo, A. M., Oleaga, L., Casas, J. A. V., Marhuenda, A., & Gómez‐Caamaño, A. (2024) · Radiographics · doi:10.1148/rg.230152 · Cited by 24
Universal Prophylactic Antitumor Vaccination Using Stem Cell Membrane‐Coated Nanoparticles
Krishnan, N., Zhou, J., Mohapatra, A., Ventura, C. J., Duan, Y., Lee, J., Hoenig, J. J., Nizet, O., Gao, W., Fang, R. H., et al. (2025) · Advanced Materials · doi:10.1002/adma.202501616 · Cited by 24
Low PD-L1 Expression Strongly Correlates with Local Recurrence in Epstein-Barr Virus-Positive Nasopharyngeal Carcinoma after Radiation-Based Therapy
Liu, Y.-J., Tsang, N., Hsueh, C., Yeh, C., Ueng, S., Wang, T., & Chuang, W. (2018) · Cancers · doi:10.3390/cancers10100374 · Cited by 23
“Recently, we have gained a better understanding of how the tumor microenvironment plays pivotal roles in determining treatment outcomes [36].”
Background
G3BP1 Depletion Increases Radiosensitisation by Inducing Oxidative Stress in Response to DNA Damage
Cho, E., Than, T. T., Kim, S.-H., Park, E., Kim, M., Lee, K. H., & SHIN, H. J. (2019) · Anticancer Research · doi:10.21873/anticanres.13816 · Cited by 25
Efficacy of late concurrent hypofractionated radiotherapy in advanced melanoma patients failing anti‐PD‐1 monotherapy
Funck‐Brentano, E., Baghad, B., Fort, M., Aouidad, I., Roger, A., Beauchet, A., Otmezguine, Y., Blom, A., Longvert, C., Boru, B., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.32934 · Cited by 24
“Radiotherapy exerts multiple actions on the immune system.(5) Preclinical data have shown that ICI combined with radiotherapy may improve tumor response.”
Background
Immunogenic Cell Death Driven by Radiation—Impact on the Tumor Microenvironment
Yamazaki, T., Vanpouille‐Box, C., Demaria, S., & Galluzzi, L. (2020) · Cancer treatment and research · doi:10.1007/978-3-030-38862-1_10 · Cited by 28
Impact of Radiotherapy on the Efficacy and Toxicity of anti-PD-1 Inhibitors in Metastatic NSCLC
Samuel, E., Lie, G., Balasubramanian, A., Hiong, A., So, Y. J., Voskoboynik, M., Moore, M. A., Shackleton, M. J., Haydon, A. M., John, T., et al. (2020) · Clinical Lung Cancer · doi:10.1016/j.cllc.2020.06.001 · Cited by 24
Foxp3+ Regulatory T Cell Depletion after Nonablative Oligofractionated Irradiation Boosts the Abscopal Effects in Murine Malignant Mesothelioma
Kohno, M., Murakami, J., Wu, L., Chan, M.-L., Yun, Z., Cho, J., & de Perrot, M. E. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000487 · Cited by 26
Combinations using checkpoint blockade to overcome resistance
Morganti, S., & Curigliano, G. (2020) · ecancermedicalscience · doi:10.3332/ecancer.2020.1148 · Cited by 25
“In the continuum between ‘cold’ and ‘hot’ tumours, an intermediate phenotype called ‘altered’ has been proposed, in which immune cells are unable to infiltrate the tumour properly (‘excluded’ phenotype) or the immunosuppressive environment limits effector actions of T-cells (‘immunosuppressed’ phenotype) [11] (Figure…”
BackgroundInfluential
Deciphering the etiology and role in oncogenic transformation of the CpG island methylator phenotype: a pan-cancer analysis
Yates, J., & Boeva, V. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab610 · Cited by 24
“Indeed, the immune activation of cancer types has been shown to correlate with classical therapies like cisplatin [90] or radiotherapy [91], as well as more recent therapies such as immune checkpoint inhibitors [92].”
Benchmarking Safety Indicators of Surgical Treatment of Brain Metastases Combined with Intraoperative Radiotherapy: Results of Prospective Observational Study with Comparative Matched-Pair Analysis
Hamed, M., Potthoff, A., Layer, J. P., Koch, D., Borger, V., Heimann, M., Scafa, D., Sarria, G. R., Holz, J. A., Schmeel, F. C., et al. (2022) · Cancers · doi:10.3390/cancers14061515 · Cited by 24
“Both direct and indirect effects trigger inflammatory cytokine signaling and local immune cell recruitment [24], which may promote healing responses of the surgical-induced intracranial wound surface, leading to a superior antimicrobial milieu and reduced risk of intracavitary side infections.”
Background
Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model
Nazari, H. G., Alimohammadi, M., Alimohammadi, R., Rostami, E., Bakhshandeh, M., Webster, T. J., Chalbatani, G. M., Tavakkol‐Afshari, J., & Jalali, S. A. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108737 · Cited by 24
Oxygen-generating materials and their biomedical applications: a review
Sun, X., Yao, F., Zhang, H., & Li, J. (2022) · Journal of Materials Science · doi:10.1007/s10853-022-07229-1 · Cited by 25
Reducing Chemo-/Radioresistance to Boost the Therapeutic Efficacy against Temozolomide-Resistant Glioblastoma
Yun, B., Gu, Z., Liu, Z., Han, Y., Sun, Q., & Li, Z. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c12348 · Cited by 24
Interfering biosynthesis by nanoscale metal-organic frameworks for enhanced radiation therapy
Fu, Z., Liu, Z., Wang, J., Deng, L., Tang, W., Tang, W., & Ni, D. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122035 · Cited by 24
Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basis
Tian, W., Chu, X., Tanzhu, G., & Zhou, R. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04089-4 · Cited by 26
“However, due to the pharmacokinetic blocking effect of therapeutic agents by the blood–brain barrier (BBB) or the blood-tumor barrier (BTB), and differentiated tumor microenvironment (TME) from the primary tumor, these treatments have rather limited efficacy in suppressing the progression of brain metastases [4].”
BackgroundInfluential
DNA repair in tumor radioresistance: insights from fruit flies genetics
Porrazzo, A., Cassandri, M., D’Alessandro, A., Morciano, P., Rota, R., Marampon, F., & Cenci, G. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00906-6 · Cited by 26
The interplay between the tumor microenvironment and tumor-derived small extracellular vesicles in cancer development and therapeutic response
Guo, X., Song, J., Liu, M., Ou, X., & Guo, Y. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2356831 · Cited by 24
“131,132 In a recent study, Zhang et al. developed a multifunctional nanocapsular system incorporating cisplatin, metronidazole, and intracapsular encapsulated TPZ.”
Background
Enhanced autophagy in colorectal cancer stem cells does not contribute to radio-resistance
Chen, Y., Luo, L., Goto, S., Urata, Y., Guo, C., Doi, H., Kitazato, K., & Li, T. (2016) · Oncotarget · doi:10.18632/oncotarget.8972 · Cited by 24
Capacity of gold nanoparticles in cancer radiotherapy
Nagi, N. M. S., Khair, Y. A. M., & Abdalla, A. M. E. (2017) · Japanese Journal of Radiology · doi:10.1007/s11604-017-0671-6 · Cited by 24
External Beam Radiation Therapy Enhances Mesenchymal Stem Cell–Mediated Sodium–Iodide Symporter Gene Delivery
Schug, C., Sievert, W., Urnauer, S., Müller, A. M., Schmohl, K. A., Wechselberger, A., Schwenk, N., Lauber, K., Schwaiger, M., Multhoff, G., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.025 · Cited by 24
“44,46,47 Radiation also drives activation of CAFs within the tumor stroma, which in turn increase growth factor secretion and the release of cytokines such as HGF, PDGF, CXCL12/SDF-1, and TGF-b .”
Influential
Bone metastasis treatment modeling via optimal control
Camacho-Gutíerrez, J. A., & Jerez, S. (2018) · Journal of Mathematical Biology · doi:10.1007/s00285-018-1281-3 · Cited by 24
Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide
Maurer, G. D., Heller, S., Wanka, C., Rieger, J., & Steinbach, J. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051061 · Cited by 24
“TIGAR might therefore facilitate resistance to radioand chemotherapy, both of which induce the formation of ROS [18,19].”
Background
On the Immunological Consequences of Conventionally Fractionated Radiotherapy
Alfonso, J. C. L., Papaxenopoulou, L. A., Mascheroni, P., Meyer‐Hermann, M., & Hatzikirou, H. (2020) · iScience · doi:10.1016/j.isci.2020.100897 · Cited by 24
Harnessing the potential of multimodal radiotherapy in prostate cancer
Philippou, Y., Sjoberg, H. T., Lamb, A. D. G., Camilleri, P., & Bryant, R. J. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0310-3 · Cited by 24
Inhibition of the thioredoxin system for radiosensitization therapy of cancer
Cao, Y., Zhou, X., Nie, Q., & Zhang, J. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116218 · Cited by 23
The Effect of Radiation Treatment of Solid Tumors on Neutrophil Infiltration and Function: A Systematic Review
Raymakers, L., Demmers, T. J., Meijer, G. J., Molenaar, I. Q., van Santvoort, H. C., Intven, M., Leusen, J. H. W., Olofsen, P. A., & Daamen, L. A. (2024) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2024.07.2141 · Cited by 23
Albumins constrainting the conformation of mitochondria-targeted photosensitizers for tumor-specific photodynamic therapy
Fang, B., Bai, H., Zhang, J., Wang, L., Li, P., Ge, Y., Yang, H., Wang, H., Peng, B., Hu, W., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122914 · Cited by 25
Chemical Synthesis and Multihybridization of Small-Sized Hollow Mesoporous Organosilica Nanoparticles Toward Advanced Theranostics
Huang, Y., Zhang, C., Zhang, L., Chen, X. S., & Fan, W. (2024) · Accounts of Chemical Research · doi:10.1021/acs.accounts.4c00502 · Cited by 23
Therapy-induced senescent glioblastoma cells sustain a procancer immune microenvironment by activating DDX58-mediated STAT1 signaling
Wang, Z., Zhang, Y., Wu, F., Qiu, B., Yin, Y., Wang, X., Huang, R., Zhang, X., Sun, Z., Tang, W., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf107 · Cited by 25
Microbial Photosynthetic Oxygenation and Radiotherapeutic Sensitization Enables Pyroptosis Induction for Combinatorial Cancer Therapy
Li, T., Zhang, Q., Li, C., Yan-wei, S., Jiang, T., Yin, Y., Chang, M., Song, X., Zheng, X., Zhang, W., et al. (2025) · Advanced Materials · doi:10.1002/adma.202503138 · Cited by 23
Biomechanics of the tumor extracellular matrix and regulatory T cells: regulatory mechanisms and potential therapeutic targets
Huang, W., Lai, H.-Z., Long, J., Dai, Z.-L., Ma, Q., Xiao, C., & You, F.-M. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02380-z · Cited by 27
“Additionally, therapeutic interventions like chemotherapy and radiation therapy stimulate CAFs to secrete more ECM components, further contributing to matrix stiffening [27, 28].”

Authors: Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J.
Affiliations: Institute of Cancer Research (GB)
Corresponding author: Barker, Holly E.
ORCID: Barker, Holly E.
Paget, James T. E.
Khan, Aadil A.
Harrington, Kevin J.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2015-06-24
Volume: 15
Issue: 7
Pages: 409-425
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc3958
PMC: PMC4896389
OpenAlex: W1912124796
Cited by: 2,144
References: 200
Citations by year: 2026: 181 · 2025: 215 · 2024: 246 · 2023: 242 · 2022: 249 · 2021: 256 · 2020: 230 · 2019: 175 · 2018: 161 · 2017: 119 · 2016: 63 · 2015: 7
FWCI: 12.40
Type: journal article
Language: en
Update notices: erratum (2015-07-24)
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Cancer Research UK (C46 ⁄ A10588, C7224/A13407, A13407, 13407)
National Institute for Health and Care Research (CL-2014-22-003)
Rosetrees Trust
Topics: Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Keywords: tumor microenvironment, radioresistance (biology), radiotherapy, tumor stroma, tumor recurrence, vascular changes, immunological changes, combination therapy, molecularly targeted agents
MeSH terms: Animals, Fibroblasts, Humans, Immune Tolerance, Neoplasm Recurrence, Local, Neoplasms, Radiation Tolerance, Cell Hypoxia, Transforming Growth Factor beta, Vascular Endothelial Growth Factor A, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks